UC HEALTH LINE: IBS vs. IBD: Similar in Name but Not the Same
But UC experts say there are many differences between the disorders, and with proper diagnosis and treatment, people with the more serious of the two can experience a better, longer life. Richard Rood, MD, a digestive diseases specialist with UC Physicians, says IBDor Inflammatory Bowel Diseaseis often confused with IBS, which is much different and less severe. IBSor Irritable Bowel Syndromeis the most common functional gastrointestinal (GI) disorder with worldwide prevalence rates ranging from 9 to 23 percent and U.S. rates generally in the area of 10 to15 percent. It causes cramping, abdominal pain, bloating, constipation and diarrhea, however, unlike IBD, it does not permanently harm the intestines and does not lead to more serious diseases, such as cancer. There are primarily two types of IBD: Crohns disease and ulcerative colitis, Rood says, noting that IBD occurs when the immune system attacks the GI tract. Ulcerative colitis affects the inner lining of the colon while Crohns can inflame all layers of the intestinal wall. Also, Crohns disease can involve any section in the digestive tract while ulcerative colitis only affects the colon and rectum. Rood, not only an IBD expert but also a person living with ulcerative colitis, says that IBS is a syndrome, not a disease, and it will not lead to colon cancer nor does it cause intestinal bleeding. Patients with IBD experience recurrent abdominal pain, bloody stools and diarrhea, among other serious problems, like growth failure because of a lack of nutrients. he says. The onset of the illness usually occurs in a persons teens or 20s, but it can affect infants all the way up to people in their 90s. He adds IBS can be controlled with diet, fiber supplements and medication while the treatment of Crohns disease and ulcerative colitis involves medications that may have significant side effects. In addition IBD may require surgery and Crohns must be medically managed. With National Colorectal Cancer Awareness Month being observed in March, Rood, also an associate professor in the digestive diseases division at UC, says that people should take extra precautions to ensure that their symptoms arent part of a larger problem. Patients with IBD have a 10 percent increase of rectal, bowel or colon cancer for each decade since diagnosis, he says. He urges patients with any of the following symptoms to seek medical attention: IBD is a very serious disease that affects more than one million people in this country alone and could have tragic outcomes, he says. However, with properand promptdiagnosis and treatment, patients can live a fulfilling life. Please, dont ignore your symptoms or attribute them to something smaller. In addition, dont be embarrassed to talk about your illness. You are not alone.
Richard Rood, MD, associate professor in the digestive diseases division and IBD expert
Tags
Related Stories
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
Ohio nurses weigh in on proposed federal loan rule
December 12, 2025
Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.